Clinical review: Optimal dose of continuous renal replacement therapy in acute kidney injury

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Prowle, John R ^a   Schneider, Antoine ^a   Bellomo, Rinaldo ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

UREA;

ACUTE KIDNEY FAILURE; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; DOSE RESPONSE; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME; EVIDENCE BASED MEDICINE; INTENSIVE CARE; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; INTENSIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 79956001896     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9415     Document Type: Review

References (44)

1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370. 10.1681/ASN.2004090740, 16177006.
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, . Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
3. Prowle JR, Bellomo R. Continuous renal replacement therapy: recent advances and future research. Nat Rev Nephrol 2010, 6:521-529. 10.1038/nrneph.2010.100, 20644583.
4. The VA/NIH Acute Renal Failure Trial Network Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359:7-20. 10.1056/NEJMoa0802639, 2574780, 18492867, The VA/NIH Acute Renal Failure Trial Network.
5. Bagshaw SM, Bellomo R, Devarajan P, Johnson C, Karvellas CJ, Kutsiogiannis DJ, Mehta R, Pannu N, Romanovsky A, Sheinfeld G, Taylor S, Zappitelli M, Gibney RT. Review article: renal support in critical illness. Can J Anaesth 2010, 57:999-1013. 10.1007/s12630-010-9376-3, 20931311.
6. Ronco C, Ricci Z. Renal replacement therapies: physiological review. Intensive Care Med 2008, 34:2139-2146. 10.1007/s00134-008-1258-6, 18791697.
7. Cole L, Bellomo R, Silvester W, Reeves JH. A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med 2000, 162:191-196.
8. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. RENAL Replacement Therapy Study Investigators Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361:1627-1638. 10.1056/NEJMoa0902413, 19846848, RENAL Replacement Therapy Study Investigators.
9. Ricci Z, Salvatori G, Bonello M, Pisitkun T, Bolgan I, D'Amico G, Dan M, Piccinni P, Ronco C. In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care 2005, 9:R266-R273. 10.1186/cc3517, 1175890, 15987400.
10. Fealy N, Baldwin I, Bellomo R. The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Crit Care Resusc 2002, 4:266-270.
11. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA. Continuous renal replacement therapy: a worldwide practice survey: The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med 2007, 33:1563-1570. 10.1007/s00134-007-0754-4, 17594074.
12. Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, René R, Livigni S, Ronco C, . DOse REsponse Multicentre International collaborative Initiative (DO-RE-MI Study Group) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009, 13:R57. 10.1186/cc7784, 2689504, 19368724, DOse REsponse Multicentre International collaborative Initiative (DO-RE-MI Study Group).
13. Lameire N, Van Biesen W, Vanholder R. Dose of dialysis in the intensive care unit: is the venom in the dose or in the clinical experience?. Crit Care 2009, 13:155. 10.1186/cc7873, 2717425, 19519962.
14. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356:26-30. 10.1016/S0140-6736(00)02430-2, 10892761.
15. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006, 70:1312-1317. 10.1038/sj.ki.5001705, 16850022.
16. Ricci Z, Ronco C, Bachetoni A, D'amico G, Rossi S, Alessandri E, Rocco M, Pietropaoli P. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care 2006, 10:R67. 10.1186/cc4903, 1550874, 16646985.
17. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008, 19:1233-1238. 10.1681/ASN.2007111173, 2396940, 18337480.
18. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002, 30:2205-2211. 10.1097/00003246-200210000-00005, 12394945.
19. Bellomo R, Warrillow SJ, Reade MC. Why we should be wary of single-center trials. Crit Care Med 2009, 37:3114-3119. 10.1097/CCM.0b013e3181bc7bd5, 19789447.
20. Palevsky PM, O'Connor TZ, Chertow GM, Crowley ST, Zhang JH, Kellum JA, . US Department of Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Crit Care 2009, 13:310. 10.1186/cc7901, 2750132, 19678919, US Department of Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network.
21. Bouman CS, Oudemans-van Straaten HM. Timing of renal replacement therapy in critically ill patients with acute kidney injury. Curr Opin Crit Care 2007, 13:656-661. 10.1097/MCC.0b013e3282f0eae2, 17975386.
22. Kellum JA, Ronco C. Dialysis: results of RENAL--what is the optimal CRRT target dose?. Nat Rev Nephrol 2010, 6:191-192. 10.1038/nrneph.2010.15, 20348928.
23. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N. Acute renal failure in critical illness. Conventional dialysis versus acute continuous hemodiafiltration. ASAIO J 1992, 38:M654-M657. 10.1097/00002480-199207000-00118, 1457942.
24. Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N. Hemofiltration and peritoneal dialysis in infectionassociated acute renal failure in Vietnam. N Engl J Med 2002, 347:895-902. 10.1056/NEJMoa020074, 12239258.
25. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, . Hemodialysis (HEMO) Study Group Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002, 347:2010-2019. 10.1056/NEJMoa021583, 12490682, Hemodialysis (HEMO) Study Group.
26. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993, 329:1001-1006. 10.1056/NEJM199309303291404, 8366899.
27. Gotch FA, Gentile DE, Keen ML, Amerling R, Folkert VW, Kliger AS, Shapiro WB. The incident patient cohort study design with uncontrolled dose. Substantial over-estimation of mortality as a function of peritoneal dialysis dose?. ASAIO J 1996, 42:M514-M517. 10.1097/00002480-199609000-00039, 8944932.
28. Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998, 13(Suppl 6):10-14. 10.1093/ndt/13.suppl_6.10, 9719197.
29. Casino FG, Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 1996, 11:1574-1581.
30. Tetta C, Bellomo R, D'Intini V, De Nitti C, Inguaggiato P, Brendolan A, Ronco C. Do circulating cytokines really matter in sepsis?. Kidney Int Suppl 2003, (84):S69-S71. 10.1046/j.1523-1755.63.s84.40.x, 12694313.
31. Joannes-Boyau O, Honore PM, Boer W. Hemofiltration: The case for removal of sepsis mediators from where they do harm. Crit Care Med 2006, 34:2244-2246. 10.1097/01.CCM.0000227650.77064.5F, 16883194.
32. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992, 18:235-240. 10.1007/BF01709839, 1430589.
33. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000, 161:1429-1436.
34. Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmüller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR. Attenuation of sepsis-related immunoparalysis by continuous venovenous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001, 29:1423-1430. 10.1097/00003246-200107000-00021, 11445702.
35. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28:3581-3587. 10.1097/00003246-200011000-00001, 11098957.
36. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004, 50:102-109. 10.1097/01.MAT.0000104846.27116.EA, 14763500.
37. Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, Spaulding C, Carli P, Dhainaut JF, Monchi M. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005, 46:432-437. 10.1016/j.jacc.2005.04.039, 16053954.
38. Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005, 9:R294-R302. 10.1186/cc3529, 1269433, 16137340.
39. Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J, Castillo L, Andresen M, Dougnac A, Bugedo G, Hernandez G. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006, 32:713-722. 10.1007/s00134-006-0118-5, 16550372.
40. Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care 2007, 22:1-12. 10.1016/j.jcrc.2006.05.002, 17371737.
41. Bellomo R, Palevsky PM, Bagshaw SM, Gibney N, McAlister FA, Honore PM, Joannes-Boyau O, Prowle J, Haase M, Cruz DN, Ronco C. Recent Trials in Critical Care Nephrology. Contrib Nephrol 2010, 165:299-309. full_text, 20427981.
42. Ronco C, Bellomo R, Kellum JA. Continuous renal replacement therapy: opinions and evidence. Adv Ren Replace Ther 2002, 9:229-244. 10.1053/jarr.2002.35561, 12382223.
43. Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Davenport P, Morgera S, Goehl H, Storr M, Boyce N, Neumayer HH. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am J Kidney Dis 2007, 50:296-304. 10.1053/j.ajkd.2007.05.003, 17660031.
44. Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006, 34:2099-2104. 10.1097/01.CCM.0000229147.50592.F9, 16763508.